CDC has updated its COVID-19 guidance for Dental settings to avoid aerosol-generating procedures in a typical dental operatory only for patients with suspected or confirmed COVID-19. It has removed the language stating that dental health care personnel should avoid aerosol-generating procedures for all patients, regardless of their COVID-19 status.

Effective for dates of service August 1, 2021 and forward, the Department of Social Services (DSS) is updating the dental guidelines concerning radiographic coverage. The dental regulations and policies have been put in place to reduce dental procedures that are not medically necessary while maintaining services that will prevent further disease and continue the maintenance of oral health.

Exparel (bupivacaine liposome injectable suspension) is the first and only non-opioid, FDA-approved long-acting local anesthesia for ages 6 and above.

Dear Colleagues,

We are writing to inform you that CDC has made an edit to the Dec. 4, 2020 COVID-19 Guidance for Dental Settings.

All people (vaccinated or unvaccinated) need to wear a mask when they are inside a healthcare facility, including dental offices.

Effective for dates of service May 21, 2021 and forward, CMAP enrolled providers MUST obtain Prior Authorization for Dental (Endodontic) Services. Providers should start the process to secure PA for Endodontic Dental Services for dates of service May 21, 2021 and forward.

Exparel which is a long – acting anesthetic (bupivacaine liposome injectable suspension) that is used instead of opioids for a variety of surgeries and for oral surgery. FDA just announced approval of using Exparel for in Pediatric Patients – children age 6 and up.

The Connecticut Dental Health Partnership has released the new dental fee schedule for children and adults that takes effect on February 02, 2021. If you have questions please call the call center at 1-855-283-3682.